Oracle shares fall as investors assess up to $50 billion AI funding plan
Reuters· 2026-02-02 11:22
Core Viewpoint - Oracle plans to raise between $45 billion to $50 billion this year to expand its cloud infrastructure, which has raised investor concerns leading to a 4% drop in shares during premarket trading [1] Group 1 - Oracle's share price fell approximately 4% in premarket trading on Monday [1] - The company aims to raise significant capital to enhance its cloud infrastructure [1] - Investor concerns have been fueled by the scale of the planned capital raise [1]
From PopMart to JD.com: Britain and China rush to forge business deals as diplomatic thaw takes hold
CNBC· 2026-02-02 11:20
Investment and Partnerships - Chinese businesses have pledged hundreds of millions of pounds in investments in the U.K. during Prime Minister Keir Starmer's visit, leading to significant bilateral business activity [2][3] - Starmer's visit resulted in £2.2 billion ($3 billion) worth of exports and £2.3 billion in market access for British businesses [3] - Pop Mart plans to establish a regional headquarters in London and open 27 new stores across Europe, creating over 150 jobs in the U.K. [8] - Chery Commercial Vehicles intends to set up a regional headquarters in Liverpool, potentially partnering with Jaguar Land Rover [8] - Asymchem is planning a major expansion in the U.K., adding 150 jobs in advanced research and development over the next five years [9] - HiTHIUM has pledged to invest £200 million in the U.K. and create 300 jobs, focusing on energy storage technologies [10] Market Access and E-commerce - The U.K.-China agreement includes promises from Beijing to broaden access for British businesses into the Chinese consumer market [12] - JD.com will assist British brands in selling to Chinese consumers and will launch its online retail platform Joybuy in the U.K. [13] - British companies have reported a deteriorating business environment in China, but a third of respondents plan to increase investments, particularly in operations and partnerships [14][15] Industry-Specific Developments - AstraZeneca announced a $15 billion investment in China to expand local R&D capabilities and increase its workforce [11] - British asset manager Schroders signed a memorandum with CATL to develop battery energy storage systems in Europe [11] - Birmingham Biotech expects around £20 million in sales in China as it scales its operations [16] - Octopus Energy Group plans to form a joint venture with China's PCG Power to trade renewable energy [17]
Alarm.com to Announce 2025 Fourth Quarter and Full Year Results on February 19, 2026
Businesswire· 2026-02-02 11:15
Core Viewpoint - Alarm.com Holdings, Inc. will report its fourth quarter and full year financial results for 2025 on February 19, 2026, after market close [1] Group 1: Financial Reporting - The financial results will be discussed in a conference call and webcast at 4:30 p.m. ET on the same day [1] - A pre-registration link is provided for the conference call, allowing participants to obtain their dial-in number and individual passcode [1] Group 2: Company Overview - Alarm.com is recognized as the leading platform for intelligently connected properties, serving millions of homeowners and businesses [3] - The company offers a comprehensive suite of solutions, including security, video surveillance, access control, active shooter detection, intelligent automation, energy management, and wellness [3] - Alarm.com's services are delivered exclusively through a trusted network of thousands of professional service providers and commercial integrators across North America and globally [3] - The company's common stock is traded on Nasdaq under the ticker symbol ALRM [3]
IBIT Vs. BTCI: Why I'm Choosing Pure Beta For The $150K Bitcoin Target
Seeking Alpha· 2026-02-02 11:13
Core Insights - The article emphasizes the importance of combining investment consulting with active intraday trading to maximize returns through a deep understanding of economics and investment analysis [1]. Group 1: Investment Strategy - The approach focuses on identifying profitable and undervalued investment opportunities primarily in the U.S. market to create a high-yield, balanced portfolio [1]. - The analysis integrates macro-economic insights with real-world trading experience to provide actionable investment ideas [1]. Group 2: Professional Background - The individual has a decade of experience in the investment field, starting in 2011, with academic qualifications in Finance and Economics [1]. - Practical experience in management and trading is highlighted as a key factor in developing true expertise beyond academic credentials [1].
SMR INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into NuScale Power Corporation, Encourages Investors and Potential Witnesses to Contact Law Firm
Prnewswire· 2026-02-02 11:11
Company Overview - NuScale Power Corporation is a provider of small modular reactor nuclear technology [2] Investigation Details - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving NuScale Power Corporation [1] - The investigation focuses on whether NuScale and certain top executives made materially false and/or misleading statements or omitted material information regarding the company's business and operations [2]
MONDAY INVESTOR DEADLINE: Blue Owl Capital Inc. (OWL) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Globenewswire· 2026-02-02 11:10
Core Viewpoint - The Blue Owl Capital Inc. is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims of undisclosed liquidity issues and significant pressure on its asset base from BDC redemptions during the specified class period [1][3]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Goldman v. Blue Owl Capital Inc., and it allows purchasers of Blue Owl securities between February 6, 2025, and November 16, 2025, to seek appointment as lead plaintiff by February 2, 2026 [1]. - Allegations include that Blue Owl did not disclose meaningful pressure on its asset base from BDC redemptions, leading to undisclosed liquidity issues and potential limitations on redemptions of certain BDCs [3]. Group 2: Financial Performance and Market Reaction - On October 30, 2025, Blue Owl reported third-quarter financial results with fee-related earnings of $376.2 million, missing consensus estimates, and performance revenue falling 33% year over year to $188,000, which led to a decline in stock price [4]. - Following the announcement of a merger agreement on November 5, 2025, between Blue Owl's direct lending businesses, the stock price fell nearly 5% due to concerns over liquidity and redemption limitations [5]. - An article published on November 16, 2025, indicated that OBDC II shareholders could face a 20% reduction in investment value due to the merger, resulting in a nearly 6% drop in Blue Owl's stock price [6].
INVESTOR DEADLINE: CoreWeave, Inc. (CRWV) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Prnewswire· 2026-02-02 11:10
Core Points - The law firm Robbins Geller Rudman & Dowd LLP is announcing a class action lawsuit against CoreWeave, Inc. for alleged violations of the Securities Exchange Act of 1934 during the class period from March 28, 2025, to December 15, 2025 [1] - Investors who suffered losses during this period can seek to be appointed as lead plaintiff in the lawsuit [2] Allegations - The lawsuit claims that CoreWeave and its executives made false or misleading statements regarding the company's ability to meet customer demand and the risks associated with reliance on a single third-party data center supplier [3] - CoreWeave's announcement of a significant deal worth up to $11.9 billion with OpenAI and its acquisition of Core Scientific, Inc. are central to the allegations [2] Impact on Share Price - Following the announcement that Core Scientific did not receive enough shareholder votes to approve its merger with CoreWeave, the share price of CoreWeave fell by over 6% [4] - On November 10, 2025, CoreWeave lowered its revenue guidance due to delays from a third-party data center developer, leading to a more than 16% drop in share price [5] - A subsequent report on December 15, 2025, revealed further delays in data center delivery, causing an additional 3.4% decline in CoreWeave's share price [6] Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased CoreWeave securities during the class period to seek appointment as lead plaintiff, representing the interests of the class [7] - Being a lead plaintiff does not affect an investor's ability to share in any potential recovery from the lawsuit [8] About the Law Firm - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [9]
Klöckner Pentaplast cuts €1.3bn in debt through Chapter 11 restructuring
Yahoo Finance· 2026-02-02 11:07
Core Viewpoint - Klöckner Pentaplast has successfully completed its restructuring under the US Chapter 11 process, significantly reducing its funded debt by approximately €1.3 billion ($1.5 billion) [1][5] Group 1: Restructuring Details - The restructuring resulted in the removal of around €1.3 billion in funded debt from Klöckner Pentaplast's balance sheet [1] - The company received an injection of €349 million in new capital to stabilize ongoing operations [1] - The US Bankruptcy Court for the Southern District of Texas approved the reorganization plan in December, following a restructuring support agreement with most financial stakeholders in November 2025 [3] Group 2: Leadership Changes - CEO Roberto Villaquiran and Michael Kaufman from Redwood Capital Management have joined the company's board of directors [2] - Andrew Berlin is anticipated to be appointed as board chairman soon, having previously served as chairman and CEO of Berlin Packaging for over 30 years [2] - The completion of the board with additional industry figures is expected in the coming weeks [2] Group 3: Future Outlook - Villaquiran expressed optimism about the company's future, stating it represents an exciting phase as Klöckner Pentaplast emerges as a financially stronger entity [4] - The new ownership demonstrates confidence in the company's business and future prospects, focusing on delivering innovative and sustainable packaging solutions globally [5]
AI predicts Palantir stock price after Q4 2025 earnings
Finbold· 2026-02-02 11:07
Core Viewpoint - Palantir Technologies is preparing to report its fourth-quarter 2025 earnings, with high expectations from investors regarding its valuation and performance, particularly in relation to its AI platform and commercial adoption [1]. Financial Performance - Management has guided fourth-quarter revenue to be between $1.327 billion and $1.331 billion, indicating approximately 61% year-over-year growth [2]. - The full-year revenue forecast has been raised to between $4.396 billion and $4.4 billion, reflecting strong demand for its AI-driven software across both government and commercial sectors [2]. - Wall Street estimates align with this outlook, projecting fourth-quarter revenue of about $1.34 billion, which represents a 61.9% increase year-over-year, and earnings per share of $0.23, a rise of over 64% [3]. Stock Price Predictions - Predictions suggest that Palantir's stock may experience volatility post-earnings, with an initial positive reaction expected, potentially pushing the stock price to the $150 to $155 range shortly after the earnings report [4][5]. - However, this initial strength may fade as investors reassess the company's valuation, leading to a possible consolidation range between $135 and $145 in subsequent sessions [6]. - A bearish scenario could see shares retreating to the $125 to $135 range if forward guidance does not exceed market expectations [7]. - Conversely, a bullish outcome would require a significant earnings beat and strong guidance for 2026, which could drive the stock above $160, potentially reaching the $170 area [8]. Analyst Sentiment - Wall Street analysts maintain a cautious stance on Palantir, with a consensus 'Hold' rating based on 18 analyst reviews, indicating a mix of optimism and valuation concerns [9]. - The average 12-month price target is set at $189.94, suggesting a 29.6% upside from the current share price, with bullish analysts predicting a rise to $235 and the most bearish outlook projecting a drop to $50 [11].
Obesity market sales potential tightens as Novo and Lilly enter new era
Reuters· 2026-02-02 11:07
Core Viewpoint - The expectation that the global market for obesity drugs would reach $150 billion in the next decade is becoming uncertain due to falling prices for GLP-1 treatments in the U.S. [1] Group 1: Market Expectations - Wall Street's long-held expectation for the obesity drug market is now in question [1] - The anticipated market size of $150 billion may not be achievable as previously thought [1] Group 2: Pricing Trends - U.S. prices for GLP-1 treatments are experiencing a decline [1] - The price drop could significantly impact revenue projections for companies involved in obesity drug development [1]